Table III.
Hematological and clinical data of all the subjects differentiated by diabetic and hypertensive conditions.
| Parameters | Diabetic and hypertensive | Diabetic or hypertensive | Not diabetic or hypertensive | P-value |
|---|---|---|---|---|
| WBC (103/μl) | 6.30±2.37 | 6.51±2.25 | 6.40±2.41 | 0.821 |
| Neutrophils (%) | 62±10 | 63±11 | 63±11 | 0.918 |
| Lymphocytes (%) | 27±9 | 26±10 | 27±10 | 0.474 |
| RBC (106/μl) | 4.35±0.63 | 4.29±0.64 | 4.18±0.55 | 0.060 |
| Hemoglobin (g/l) | 135±32 | 129±20 | 131±25 | 0.609 |
| RDW (%) | 13.4±1.0 | 13.5±0.9 | 13.6±1.2 | 0.763 |
| Creatinine (μmol/l) | 83.8±26.3 | 83.4±31.3 | 78.1±26.2 | 0.245 |
| CK (U/l) | 79 (51–137) | 77 (54–126) | 81 (52–132) | 0.090 |
| LDH (U/l) | 165 (135–208) | 158 (131–202) | 164 (137–191) | 0.125 |
| CRP (mg/l) | 1.32 (0.44–5.10) | 1.20 (0.37–4.40) | 1.26 (0.46–4.80) | 0.962 |
| FRS | 8.9±4.2 | 8.2±4.1 | 7.9±3.1 | 0.001 |
WBC, white blood cell; RBC, red blood cell; RDW, red cell distribution width; CK, creatine kinase; LDH, lactate dehydrogenase; CRP, C-reactive protein; FRS, Framingham risk score.